Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research is a clinical research site located in Hartford, Connecticut, United States 06102-5037.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research has participated in 1 clinical trials.
Therapeutic areas: Breast Cancer.
Sponsors: Genentech, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research has 1 clinical trials on record. Their work covers Breast Cancer.
Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.